Director, Chemistry
CurrentDeveloped novel antibody-oligonucleotide conjugates to treat rare muscle disorders. Developed analytical methods to characterize antibody-oligonucleotide conjugate purity and stability.Scaled antibody-siRNA conjugate production and purification from microgram scale for HTS to multi-gram scale for NHP studies.Managed manufacturing of oligonucleotide and.